Description
Zegfrovy 150 mg Tablet contains Sunvozertinib, a next-generation EGFR tyrosine kinase inhibitor (TKI) developed to specifically target EGFR exon 20 insertion mutations in patients with non-small cell lung cancer (NSCLC).
Traditional EGFR inhibitors show limited efficacy against exon 20 insertion mutations, but Sunvozertinib has demonstrated strong clinical results, improving response rates and survival outcomes in previously treated patients. It works by selectively inhibiting mutant EGFR kinase activity, thereby blocking cancer cell proliferation and tumor growth.
Medical Uses of Zegfrovy 150 mg:
Treatment of EGFR exon 20 insertion-positive NSCLC
For adult patients with locally advanced or metastatic disease
Effective in patients who have progressed on prior chemotherapy or EGFR therapy
Key Benefits:
Advanced targeted therapy for resistant EGFR mutations
Improved tumor response and progression-free survival
Designed to overcome limitations of first- and second-generation TKIs
Convenient once-daily oral dosing
How to Use:
The recommended dose of Zegfrovy is 150 mg orally once daily, with or without food, or as directed by the treating oncologist.
Possible Side Effects:
Diarrhea, rash, nausea, fatigue, decreased appetite, and elevated liver enzymes. Serious but less common effects include interstitial lung disease and heart rhythm disturbances.
FAQs :
What is Zegfrovy 150 mg Tablet used to treat?
Zegfrovy is a targeted therapy used to treat adult patients with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) that has a specific genetic alteration: Epidermal Growth Factor Receptor (EGFR) exon 20 insertion mutations. It is typically prescribed after the disease has progressed on or after platinum-based chemotherapy.
What are the most common side effects of Zegfrovy?
Common adverse reactions include diarrhea, rash (acneiform dermatitis), decreased appetite, fatigue, and gastrointestinal issues. Frequent lab abnormalities include increased creatinine and decreased hemoglobin. Severe side effects, such as Interstitial Lung Disease (ILD) or serious skin/eye issues, require immediate medical attention.
Can I obtain Zegfrovy 150 mg Tablets in India, or purchase them online?
Zegfrovy (Sunvozertinib) is a specialized, prescription-only medication. While it may not be commercially available through standard pharmacies in India yet, it can often be legally accessed via specialized import services and online facilitators, such as drugsgeneral.com, using the Named Patient Program (NPP). A valid prescription from a licensed doctor is strictly required for this process.
